Fact Sheets
Patient Resources
Our patient resources are designed to help you understand, manage, and live well with neuroendocrine cancer.
Here you’ll find practical tools and information to guide you through every stage of your journey, from diagnosis and treatment to living with neuroendocrine cancer day to day.
These resources are created and reviewed by experts to ensure they’re accurate, reliable, and easy to understand.
Filter by:
Or browse by
popular tag:
If you are unsure of any information, please contact our NET Nurses on 1300 287 363 or speak with your healthcare professional.
Should you require fact sheets in another language please click through below to the International Neuroendocrine Cancer Alliance (INCA) website fact sheet area for Arabic, Chinese (Mandarin), English, French, German, Hindi, Italian, Japanese, Russian and Spanish versions.
Wellness
Parenting through Cancer
Clinical Trials
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)
PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources
Patient Card – Bathroom
Other Resources
Patient Card – Medical Alert
Educational Videos, Explainer Videos
Peptide receptor radionuclide therapy (PRRT)
Clinical Trials
Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients
The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Causes & Risk Factors
Potential Carcinogens and Neuroendocrine Tumour Risk
Wellness
Preparing for the holiday season
Prognosis
Prognosis in Rare and Aggressive Neuroendocrine Cancers
Prognosis
Prognostic Significance of Tumour Grade in NETs
Fact Sheets
PRRT
Treatment Options
PRRT Treatment
Fact Sheets
Psychological Tips and Mental Health
Fact Sheets
Questions to Ask
Educational Videos
